A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

Trial Identifier:	D8460C00003
Sponsor:	AstraZeneca
Start Date:	March 2026
Primary Completion Date:	February 2027
Study Completion Date:	February 2027
Condition:	Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, AZ	Chandler, AZ, US, 85225
US, CA	Rialto, CA, US, 92377
US, FL	Miami Lakes, FL, US, 33014
US, TX	San Antonio, TX, US, 78215

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.